{"id":"W2153022550","doi":"10.1093/annonc/mdu165.25","title":"Subgroup Analyses Based on Liver Metastases and the Number of Metastatic Sites from the Mpact Phase III Trial of Nab-Paclitaxel Plus Gemcitabine Vs Gemcitabine Alone for Metastatic Pancreatic Cancer","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Gemcitabine; Metastatic breast cancer; Clinical endpoint; Internal medicine; Oncology; Paclitaxel; Performance status; Subgroup analysis; Metastasis; Nab-paclitaxel; Chemotherapy; Cancer; Urology; Confidence interval; Randomized controlled trial; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004249723,0.001939727,0.006074173,0.000845392,0.0004135942,0.001791594,0.001153318,0.001572176,0.003130456],"category_scores_gemma":[0.005506599,0.0006114863,0.01531551,0.0009147994,0.0005010417,0.001371926,0.000933348,0.003843721,0.0003084627],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009224113,"about_ca_system_score_gemma":0.001257514,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002079176,"about_ca_topic_score_gemma":0.005010144,"domain_scores_codex":[0.9970338,0.001220367,0.0003535128,0.0005470043,0.000315297,0.0005299699],"domain_scores_gemma":[0.9979949,0.0009464002,0.0002988275,0.0003816558,0.0001076739,0.0002705137],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7907218,0.0006549623,0.04907505,0.00188835,0.1129127,0.0006536283,0.000280981,0.004865877,0.008679342,0.0006114459,0.005947206,0.02370858],"study_design_scores_gemma":[0.2172558,0.06382181,0.3601555,0.0005749494,0.3047804,0.001189687,0.001533852,0.02142036,0.006119079,0.009751924,0.01284903,0.0005476049],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9768295,0.01244197,0.001839648,0.0009381787,0.001448834,0.0005466843,0.003765781,0.0000985088,0.002090884],"genre_scores_gemma":[0.9934005,0.001036861,0.0005575658,0.0005944745,0.0003774859,0.0005326986,0.001766115,0.00004821215,0.001686138],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006074173,"threshold_uncertainty_score":0.02247494,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08409434528319716,"score_gpt":0.4103033320384105,"score_spread":0.3262089867552134,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}